Indivior Pharmaceuticals, Inc. (INDV) Net income 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$210.0MFY2025 · since FY2022: -$42.0M → $210.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $210.0M | +2900.0% |
| FY2024 | $7.0M | +105.6% |
| FY2023 | -$126.0M | -200.0% |
| FY2022 | -$42.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice